211
Viking Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
167
FY23:
367
FY24:
907
FY25:
716
(positive)
Change from FY21 to FY25
millions USD
FY21:
0.13
FY22:
1.49
FY23:
1.27
FY24:
1.11
FY25:
0.13
Total assets
Change from FY21 to FY25
millions USD
FY21:
211
FY22:
169
FY23:
368
FY24:
908
FY25:
716
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
8.78
FY22:
21.9
FY23:
19.1
FY24:
27.4
FY25:
76.7
(negative)
millions USD
FY21:
0
FY22:
1.26
FY23:
0.94
FY24:
0.63
FY25:
0
(positive)
Change from FY21 to FY25
millions USD
FY21:
202
FY22:
145
FY23:
348
FY24:
880
FY25:
639
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
211
FY22:
169
FY23:
368
FY24:
908
FY25:
716
All amounts in millions USD